Burning Rock Biotech (BNR) Debt Ratio (2019 - 2026)

Burning Rock Biotech (BNR) posted quarterly Debt Ratio of 0.0 for Q1 2026, up 3.97% quarter-over-quarter from 0.0 in Q4 2025.

Burning Rock Biotech (BNR) Debt Ratio (2019 - 2026) Analysis & Trends

Burning Rock Biotech's Debt Ratio history runs 6 years deep, the most recent figure standing at 0.0 for Q1 2026.

  • In Q1 2026, Debt Ratio changed N/A year-over-year to 0.0; the TTM figure through Mar 2026 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.0, changed N/A from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.0, up from 0.0 in the prior quarter.
  • The five-year high for Debt Ratio was 0.0 in Q2 2025, with the low at 0.0 in Q2 2022.
  • The 3-year median for Debt Ratio is 0.0 (2025), against an average of 0.0.
  • Peak annual rise in Debt Ratio reached 89.26% in 2022, while the deepest fall reached 89.26% in 2022.
  • Burning Rock Biotech's Debt Ratio stood at 0.0 in 2022, then soared by 81.8% to 0.0 in 2025, then climbed by 3.97% to 0.0 in 2026.
  • Business Quant data shows BNR's Debt Ratio at 0.0 in Q1 2026, 0.0 in Q4 2025, and 0.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Thermo Fisher Scientific 213.44 Bn 209.37 Bn 8.34 Bn 0.40
2 Danaher 139.95 Bn 135.60 Bn 3.61 Bn 0.29
3 Idexx Laboratories 46.16 Bn 45.96 Bn 779.09 Mn 0.24
4 Agilent Technologies 39.67 Bn 37.87 Bn 990.00 Mn 0.26
5 Iqvia Holdings 39.29 Bn 37.21 Bn 1.44 Bn 0.54
6 Natera 38.61 Bn 37.51 Bn 696.04 Mn 0.01
7 Illumina 29.99 Bn 28.82 Bn 770.00 Mn 0.22
8 Mettler Toledo International 28.57 Bn 28.51 Bn 650.22 Mn 0.58
9 Quest Diagnostics 26.17 Bn 25.55 Bn 1.03 Bn 0.33
10 Burning Rock Biotech 781.17 Mn 711.04 Mn 11.31 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Jun 30, 2022 0.00
Dec 31, 2021 0.00
Jun 30, 2021 0.01
Mar 31, 2021 0.01
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.02
Dec 31, 2019 0.07